Martinez-Mier Gustavo, Cisneros-Tinoco Miguel Angel, Sanchez-Ruiz Francisco Gerardo
Department of Research, UMAE HE 14 CMN Adolfo Ruiz Cortines, Veracruz, Mexico.
Department of Vascular Surgery, UMAE HE 14 CMN Adolfo Ruiz Cortines, Veracruz, Mexico.
J Vasc Access. 2023 Jul;24(4):599-605. doi: 10.1177/11297298211044023. Epub 2021 Sep 8.
There is no consensus of the optimal arterial and venous sizes on arteriovenous fistula (AVF) function and patency. The purpose of our study was to determine the influence of vein and artery sizes on maturation and patency in autologous first time AVF in a vascular access clinic of Mexican Social Security.
Approved IRB single-center retrospective study in patients referred for their first AVF from 01/2018/ to 04/2020. Perianastomotic inner vein diameter and single inner artery diameter was recorded by duplex ultrasound. Outcomes were: failure to mature (FTM) and cumulative primary patency survival.
Eighty-six AVF's were created (mean age 45.5 ± 15.1 years; 62.8% male; mean BMI 25.9 ± 4.3 kg/m). About 86% were brachiocephalic AVF. Eight (8.1%) AVF had FTM. Mean follow-up was 19.7 ± 8.5 months. Two-year patency survival was 81.4%. FTM vein and artery diameters (2.1 ± 0.3 and 2.8 ± 0.7 mm respectively) were smaller than successful AVF's (3.1 ± 0.9 and 3.5 ± 0.6 mm) ( < 0.05). ROC curve calculated a 2.15 mm vein diameter cutoff (AUC: 0.86) and a 2.95 mm artery diameter cutoff (AUC: 079) for FTM AVF's (83% sensitivity, 72% specificity both) ( < 0.05). AVF's created with a vein diameter <2.15 mm and <2.95 mm artery diameter had statistically significant lower patency survival than AVF's with larger vein and artery diameters ( < 0.05).
Vein diameter <2.15 mm and artery diameter <2.95 mm influences AVF maturation and patency in a Mexican population.
关于动静脉内瘘(AVF)功能和通畅性的最佳动静脉尺寸尚无共识。我们研究的目的是在墨西哥社会保障的血管通路诊所中确定静脉和动脉尺寸对自体首次AVF成熟和通畅性的影响。
批准的IRB单中心回顾性研究,研究对象为2018年1月至2020年4月因首次AVF转诊的患者。通过双功超声记录吻合口周围内静脉直径和单根内动脉直径。结果指标为:成熟失败(FTM)和累积原发性通畅生存率。
共创建了86个AVF(平均年龄45.5±15.1岁;62.8%为男性;平均BMI 25.9±4.3kg/m)。约86%为头臂型AVF。8个(8.1%)AVF出现成熟失败。平均随访时间为19.7±8.5个月。两年通畅生存率为81.4%。成熟失败的AVF的静脉和动脉直径(分别为2.1±0.3和2.8±0.7mm)小于成功的AVF(3.1±0.9和3.5±0.6mm)(P<0.05)。ROC曲线计算出FTM AVF的静脉直径截断值为2.15mm(AUC:0.86)和动脉直径截断值为2.95mm(AUC:0.79)(敏感性和特异性均为83%)(P<0.05)。静脉直径<2.15mm且动脉直径<2.95mm创建的AVF的通畅生存率在统计学上显著低于静脉和动脉直径较大的AVF(P<0.05)。
静脉直径<2.15mm和动脉直径<2.95mm会影响墨西哥人群中AVF的成熟和通畅性。